Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
SciNeuro Pharmaceuticals Launches to Bring Innovative Treatments for ...
SciNeuro Initiates Phase 1 Clinical Trial with SNP318, a Novel Lp-PLA2 ...
SciNeuro
Careers - SciNeuro Pharmaceuticals
SciNeuro Pharmaceuticals 2026 Company Profile: Valuation, Funding ...
Novartis, SciNeuro Brain Shuttle Deal Expands Neuroscience
SciNeuro Pharmaceuticals and Alamar Biosciences Collaborate to Discover ...
#biotech #neuroscience #r #lifesciences #hiring #innovation | SciNeuro ...
SciNeuro Pharmaceuticals on LinkedIn: SciNeuro completes dosing in its ...
Deciphering the Enigma of Brain Disease - SciNeuro Pharmaceuticals
News - SciNeuro Pharmaceuticals
SciNeuro and Novartis Enter into a Licensing and Collaboration ...
#researchanddevelopment #workplace #biotech #innovation | SciNeuro ...
SciNeuro Pharmaceuticals | LinkedIn
Novartis Enters Landmark $1.7 Billion Licensing Agreement with SciNeuro ...
SciNeuro ve Novartis, Alzheimer Tedavisinde Yeni Nesil Terapötikler ...
SciNeuro Forges ~$1.7B Deal with Novartis to Advance Therapeutics for ...
SciNeuro Pharmaceuticals on LinkedIn: #drugdiscovery #antibodies # ...
BioCentury - SciNeuro reunites GSK R&D vets to bring CNS therapies to China
SciNeuro lands $53m to address the underlying biology of neurodegeneration
SciNeuro gets grant for Parkinson's treatment from MJFF | SciNeuro ...
Science - SciNeuro Pharmaceuticals
SciNeuro Partners with Novartis for Alzheimer's Disease Treatment ...
Secarna Pharmaceuticals und SciNeuro Pharmaceuticals schließen ...
Our Team_draft - SciNeuro Pharmaceuticals
Pipeline - SciNeuro Pharmaceuticals
Endpoints at #BIO23: The dawn of a new biotech era | SciNeuro ...
SciNeuro Pharmaceuticals secures $53 million in equity financing for ...
SciNeuro Raises $53M in Funding, Appoints New CFO Hogan Wan | SciNeuro ...
About Us - SciNeuro Pharmaceuticals
SciNeuro Pharmaceuticals Appoints Guojun Bu, Ph.D., as Chief Scientific ...
SciNeuro and Novartis ink $1.7b deal for new Alzheimer’s treatment
SciNeuro to Join Endpoints Roundtable at BIO 2023 - SciNeuro ...
Our Team - SciNeuro Pharmaceuticals
SciNeuro Pharmaceuticals to Accelerate Novel LRRK2 Therapeutic (SNP614 ...
JPM26: SciNeuro and Novartis sign global licensing deal for Alzheimer’s ...
SciNeuro raises $53m — to revive a former GSK neuro compound | BioBriefs
Novartis erwirbt Lizenz für Entwicklung von Alzheimer-Therapie von SciNeuro
SciNeuro Pharmaceuticals Announces $53 Million Financing to Further ...
SciNeuro e Novartis fecham acordo de até US$ 1,7 bilhão para Alzheimer ...
SciNeuro Participated in Alzheimer’s and Parkinson’s Disease Conference ...
SciNeuro and Novartis Unite to Tackle Alzheimer's with New Therapy ...
SciNeuro and Novartis enter into extensive collaboration for next ...
Huei-Ying Chen - Senior Scientist at SciNeuro Pharmaceuticals | The Org
Novartis, SciNeuro to work together on preclinical amyloid-targeting ...
Secarna Pharmaceuticals partners with SciNeuro Pharmaceuticals ...
Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro - BioSpace
SciNeuro Pharmaceuticals Launches to Bring Innovative T...
Novartis pays SciNeuro $165M for ticket on brain shuttle
Secarna, SciNeuro Enter Research Agreement for CNS Diseases | Contract ...
SciNeuro inks licenscing deal with Eli Lilly for targeted antibody ...
SciNeuro Pharmaceuticals Announces $53 Million Financing | citybiz
SciNeuro | General Atlantic
SciNeuro and Novartis Enter into a Licensing and Collaborati...
Maryland-based SciNeuro Closes $53M Raise to Advance Neurodegenerative ...
Lisa Li - SVP, Head of China Clinical Development at SciNeuro ...
Novel Therapeutic Antibodies for CNS Diseases Collaboration
#antibodies #biologics #drugdiscovery | Christopher Bunker, Ph.D., M.B.A.
An Arch-backed biotech raises $53M to fight neurodegeneration ...
Bayerische Antisense-Technologie findet weiteren Partner in Kalifornien
SciNeuro, Novartis Partner On Next-Gen Alzheimer’s Therapeutics
Lp-PLA2 - Drugs, Indications, Patents - Synapse
Novartis Bets Big on Alzheimer's with $1.7 B Licensing Deal with ...
诺华17亿美元豪赌中国SciNeuro:双特异性"脑穿梭"抗体SNP234能否改写阿尔茨海默病治疗史? - 知乎
US$1.7 billion SciNeuro-Novartis deal offers hope for 55 million ...
Novartis Licenses SciNeuro’s Alzheimer’s Antibody Globally
Novartis has entered into a licensing and collaboration agreement with ...
脳に届かない抗体を“届く”へ変える技術!ノバルティス×中国SciNeuro提携の全貌:ノバルティスが17億ドル賭けた「脳内送達」革命:TfR× ...
SciNeuro, Novartis sign $1.7 billion licensing deal to develop ...
Frontiers in Computational Neuroscience - Frontiers 出版社官方中文网站
Cision - MediaStudio View Media